Request Demo
Last update 04 Jun 2025
Group ACYW135 Meningococcal Conjugate Vaccine(Beijing Luzhu Biopharmaceutical)
Last update 04 Jun 2025
Overview
Basic Info
Drug Type Prophylactic vaccine, Conjugated vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with Group ACYW135 Meningococcal Conjugate Vaccine(Beijing Luzhu Biopharmaceutical)NCT05252715
A Single-center, Randomized, Blind, Positive Control Phase III Clinical Trial to Evaluate Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged From 3 to 5 Months
CTR20212286
单中心、随机、盲法、阳性对照评价ACYW135群脑膜炎球菌多糖结合疫苗在3-5月龄婴幼儿中安全性和免疫原性的Ⅲ期临床试验
[Translation] A single-center, randomized, blinded, positive-controlled phase III clinical trial to evaluate the safety and immunogenicity of group ACYW135 meningococcal polysaccharide conjugate vaccine in infants aged 3-5 months
CTR20212884
单中心、随机、盲法、阳性对照评价 ACYW135 群脑膜炎球菌多糖结合疫苗在 6 月龄-5 岁婴幼儿及儿童中安全性和免疫原性的Ⅲ期临床试验
[Translation] A single-center, randomized, blinded, positive-controlled phase III clinical trial to evaluate the safety and immunogenicity of group ACYW135 meningococcal polysaccharide conjugate vaccine in infants and children aged 6 months to 5 years
100 Clinical Results associated with Group ACYW135 Meningococcal Conjugate Vaccine(Beijing Luzhu Biopharmaceutical)
Login to view more data
100 Translational Medicine associated with Group ACYW135 Meningococcal Conjugate Vaccine(Beijing Luzhu Biopharmaceutical)
Login to view more data
100 Patents (Medical) associated with Group ACYW135 Meningococcal Conjugate Vaccine(Beijing Luzhu Biopharmaceutical)
Login to view more data
100 Deals associated with Group ACYW135 Meningococcal Conjugate Vaccine(Beijing Luzhu Biopharmaceutical)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Meningitis, Meningococcal | NDA/BLA | China | 30 May 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 3 | - | sgiahzrebz(wjycxwhshj) = 全面达到临床试验预设目标。 gfelgpmipl (wszbwtsbye ) Met | Positive | 08 Apr 2025 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free